Emerging Endocrine Therapies in the Treatment of HR-Positive Metastatic Breast Cancer

E-ISSN： 1875-6301|12|1|37-53

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.12, Iss.1, 2016-10, pp. : 37-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurocognitive Effects of Chemotherapy and Endocrine Therapies in the Treatment of Breast Cancer: Recent Perspectives

By Walker Caroline H. Drew Barbara A. Antoon James W. Kalueff Alan V. Beckman Barbara S.

Cancer Investigation, Vol. 30, Iss. 2, 2012-02 ,pp. : 135-148

Informa Healthcare

Access to resources Recommend Favorite

Influence of Droloxifene on Metastatic Breast Cancer as First-Line Endocrine Treatment

By Haarstad Helge Lønning Per E. Gundersen Stein Wist Erik Raabe Nils Kvinnsland Stener

Acta Oncologica, Vol. 37, Iss. 4, 1998-10 ,pp. : 365-368

Informa Healthcare

Access to resources Recommend Favorite

New Endocrine Therapies for Breast Cancer

By Howell A. Downey S. Anderson E.

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 576-588

Elsevier

Access to resources Recommend Favorite

Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe

By Piccart M.J.

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia Pronzato Paolo Del Mastro Lucia

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite